NCT06566768View on ClinicalTrials.gov

Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

June 13, 2025

Study Completion Date

June 13, 2025

Conditions
Healthy Participants
Interventions
DRUG

Deucravacitinib

Specified dose on specified days

Trial Locations (1)

NG11 6JS

Local Institution - 0001, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06566768 - Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants | Biotech Hunter | Biotech Hunter